ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for SLNO

Stock NameSoleno Therapeutics Inc
TickerSLNO(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS8342032005

Show aggregate SLNO holdings

News associated with SLNO

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of “Buy” by Brokerages
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been assigned an average rating of “Buy” from the twelve research firms that are presently covering the firm, Marketbeat reports. Eleven analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year […] - 2025-08-28 02:24:50
Notable Friday Option Activity: CSCO, SLNO, MDB
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cisco Systems Inc (Symbol: CSCO), where a total volume of 148,281 contracts has been traded thus far today, a contract volume which is representative of approxim - 2025-08-15 16:27:16
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $108.70 Consensus Price Target from Brokerages
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has received a consensus recommendation of “Buy” from the eleven analysts that are presently covering the company, Marketbeat.com reports. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target […] - 2025-08-06 02:30:59
Soleno Therapeutics (NASDAQ:SLNO) Raised to “Hold” at Wall Street Zen
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other analysts also recently weighed in on the company. HC Wainwright restated a “buy” rating and set a $100.00 target price on shares of Soleno Therapeutics […] - 2025-07-28 04:00:47
Arizona State Retirement System Has $527,000 Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Arizona State Retirement System boosted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,380 shares of the company’s stock after purchasing an additional 620 shares during the […] - 2025-07-22 07:43:03
Arizona State Retirement System Has $527,000 Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Arizona State Retirement System boosted its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,380 shares of the company’s stock after buying an additional 620 shares during […] - 2025-07-22 06:56:57
Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $121.00
Soleno Therapeutics (NASDAQ:SLNO – Free Report) had its target price lifted by Robert W. Baird from $105.00 to $121.00 in a research note released on Friday morning,Benzinga reports. They currently have an outperform rating on the stock. A number of other equities analysts have also weighed in on SLNO. Stifel Nicolaus increased their target price […] - 2025-07-14 03:30:49
Avior Wealth Management LLC Grows Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Avior Wealth Management LLC grew its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 72.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,410 shares of the company’s stock after buying an additional 1,437 shares during […] - 2025-06-24 04:52:53
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $106.78 Average Target Price from Brokerages
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have earned an average recommendation of “Buy” from the nine research firms that are currently covering the firm, MarketBeat.com reports. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price […] - 2025-06-17 03:08:55
California State Teachers Retirement System Has $988,000 Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
California State Teachers Retirement System boosted its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 23.6% in the fourth quarter, HoldingsChannel reports. The firm owned 21,977 shares of the company’s stock after acquiring an additional 4,201 shares during the period. California State Teachers Retirement System’s holdings in Soleno Therapeutics were worth […] - 2025-06-11 05:04:47
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 24.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,504 shares of the company’s stock […] - 2025-06-10 04:20:47
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Bought by ProShare Advisors LLC
ProShare Advisors LLC lifted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 64.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,206 shares of the company’s stock after buying an additional 2,836 shares during […] - 2025-05-30 05:06:50
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Average Recommendation of “Buy” from Analysts
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has earned an average recommendation of “Buy” from the nine research firms that are covering the stock, MarketBeat reports. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among […] - 2025-05-20 02:31:41
Deutsche Bank AG Purchases 36,971 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Deutsche Bank AG grew its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 44.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 119,455 shares of the company’s stock after buying an additional 36,971 shares during the period. Deutsche Bank […] - 2025-05-19 05:07:01
BNP Paribas Financial Markets Purchases New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
BNP Paribas Financial Markets purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 71,320 shares of the company’s stock, valued at approximately $3,206,000. BNP Paribas Financial Markets owned 0.17% of Soleno Therapeutics […] - 2025-05-16 05:08:56
Reviewing Soleno Therapeutics (NASDAQ:SLNO) & Guided Therapeutics (OTCMKTS:GTHP)
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Profitability This table compares Soleno Therapeutics and Guided […] - 2025-04-29 02:22:53
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Legal & General Group Plc
Legal & General Group Plc grew its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 23,471 shares of the company’s stock after purchasing an additional 1,983 shares during the quarter. Legal & General Group Plc’s holdings in Soleno Therapeutics were worth […] - 2025-04-28 04:56:52
Brokerages Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) PT at $104.67
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has been assigned an average rating of “Buy” from the ten brokerages that are presently covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 month price […] - 2025-04-28 02:39:09
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $94.57 Consensus PT from Brokerages
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been assigned an average recommendation of “Buy” from the nine ratings firms that are presently covering the company, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average […] - 2025-04-03 02:35:01
Soleno Therapeutics (NASDAQ:SLNO) Sees Strong Trading Volume Following Analyst Upgrade
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) saw unusually-high trading volume on Monday after HC Wainwright raised their price target on the stock from $70.00 to $100.00. HC Wainwright currently has a buy rating on the stock. Approximately 891,497 shares traded hands during mid-day trading, an increase of 40% from the previous […] - 2025-04-01 02:54:47
Stocks Finish Lower as Tariffs Cloud the Economic Outlook
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.37%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.59%. June E-mini S&P futures (ESM25 ) are down -0.32%, and June E-mini Nasdaq futures... - 2025-03-28 10:31:16
Swiss National Bank Boosts Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Swiss National Bank lifted its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 27.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 45,900 shares of the company’s stock after purchasing an additional 9,900 shares during the quarter. Swiss National […] - 2025-03-28 06:28:50
Stocks Trade Mixed on Strong Economic Data, Lingering Tariff Uncertainty
The S&P 500 Index ($SPX ) (SPY ) today is down -0.12%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.25%. June E-mini S&P futures (ESM25 ) are down -0.07%, and June E-mini Nasdaq futures... - 2025-03-27 19:46:46
Stocks Bounce Back as Investors Shrug Off Auto Tariffs
The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.32%. June E-mini S&P futures (ESM25 ) are up +0.29%, and June E-mini Nasdaq futures... - 2025-03-27 18:09:37
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Rating of “Buy” from Brokerages
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have received an average recommendation of “Buy” from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target […] - 2025-03-06 05:21:27
Soleno Therapeutics (NASDAQ:SLNO) Earns “Buy” Rating from HC Wainwright
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They presently have a $70.00 target price on the stock. HC Wainwright’s price objective would indicate a potential upside of 57.52% from the company’s previous close. A number of other […] - 2025-03-05 05:04:52
Allspring Global Investments Holdings LLC Decreases Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
Allspring Global Investments Holdings LLC trimmed its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 128,028 shares of the company’s stock after selling 13,396 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Soleno Therapeutics were worth $5,755,000 […] - 2025-02-20 06:24:48
Soleno Therapeutics (NASDAQ:SLNO) Upgraded at Lifesci Capital
Lifesci Capital upgraded shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) to a strong-buy rating in a research report report published on Tuesday morning,Zacks.com reports. Lifesci Capital also issued estimates for Soleno Therapeutics’ Q4 2024 earnings at ($0.37) EPS, Q1 2025 earnings at ($1.67) EPS, Q2 2025 earnings at ($1.13) EPS, Q3 2025 earnings at […] - 2025-02-07 06:36:55

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc SLNO holdings

DateNumber of SLNO Shares HeldBase Market Value of SLNO SharesLocal Market Value of SLNO SharesChange in SLNO Shares HeldChange in SLNO Base ValueCurrent Price per SLNO Share HeldPrevious Price per SLNO Share Held
2025-12-11 (Thursday)24,061USD 1,190,779SLNO holding decreased by -12271USD 1,190,7790USD -12,271 USD 49.49 USD 50
2025-12-10 (Wednesday)24,061USD 1,203,050SLNO holding decreased by -241USD 1,203,0500USD -241 USD 50 USD 50.01
2025-12-09 (Tuesday)24,061USD 1,203,291SLNO holding decreased by -28151USD 1,203,2910USD -28,151 USD 50.01 USD 51.18
2025-12-08 (Monday)24,061USD 1,231,442SLNO holding decreased by -4572USD 1,231,4420USD -4,572 USD 51.18 USD 51.37
2025-12-05 (Friday)24,061USD 1,236,014SLNO holding decreased by -31519USD 1,236,0140USD -31,519 USD 51.37 USD 52.68
2025-12-04 (Thursday)24,061USD 1,267,533SLNO holding increased by 47159USD 1,267,5330USD 47,159 USD 52.68 USD 50.72
2025-12-03 (Wednesday)24,061SLNO holding decreased by -420USD 1,220,374SLNO holding increased by 42471USD 1,220,374-420USD 42,471 USD 50.72 USD 48.115
2025-12-02 (Tuesday)24,481SLNO holding increased by 168USD 1,177,903SLNO holding decreased by -13920USD 1,177,903168USD -13,920 USD 48.115 USD 49.02
2025-12-01 (Monday)24,313USD 1,191,823SLNO holding decreased by -34768USD 1,191,8230USD -34,768 USD 49.02 USD 50.45
2025-11-28 (Friday)24,313USD 1,226,591SLNO holding increased by 21882USD 1,226,5910USD 21,882 USD 50.45 USD 49.55
2025-11-27 (Thursday)24,313USD 1,204,709USD 1,204,7090USD 0 USD 49.55 USD 49.55
2025-11-26 (Wednesday)24,313USD 1,204,709SLNO holding decreased by -5349USD 1,204,7090USD -5,349 USD 49.55 USD 49.77
2025-11-25 (Tuesday)24,313SLNO holding decreased by -252USD 1,210,058SLNO holding increased by 82279USD 1,210,058-252USD 82,279 USD 49.77 USD 45.91
2025-11-24 (Monday)24,565SLNO holding increased by 9264USD 1,127,779SLNO holding increased by 437551USD 1,127,7799,264USD 437,551 USD 45.91 USD 45.11
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SLNO by Blackrock for IE00B3VWM098

Show aggregate share trades of SLNO

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03SELL-420 50.720* 62.83 Profit of 26,387 on sale
2025-12-02BUY168 48.115* 62.90
2025-11-25SELL-252 49.770* 63.22 Profit of 15,931 on sale
2025-11-24BUY9,264 45.910* 63.30
2025-11-17SELL-572 47.250* 63.73 Profit of 36,451 on sale
2025-11-12SELL-52 47.730* 63.96 Profit of 3,326 on sale
2025-11-06SELL-572 43.540* 64.33 Profit of 36,794 on sale
2025-11-04SELL-104 63.850* 64.42 Profit of 6,700 on sale
2025-11-03SELL-10469.99064.900 65.409USD -6,803 64.41 Loss of -104 on sale
2025-10-28BUY15668.66069.280 69.218USD 10,798 64.32
2025-10-24SELL-5264.18065.000 64.918USD -3,376 64.30 Loss of -32 on sale
2025-10-15BUY31267.67067.740 67.733USD 21,133 64.22
2025-10-02BUY5257.98060.268 60.039USD 3,122 64.29
2025-09-30BUY10467.60068.460 68.374USD 7,111 64.29
2025-08-21SELL-4369.80070.130 70.097USD -3,014 64.32 Loss of -248 on sale
2025-07-31BUY12986.47087.570 87.460USD 11,282 64.16
2025-06-30SELL-8683.78086.790 86.489USD -7,438 61.37 Loss of -2,160 on sale
2025-06-25SELL-4385.79086.670 86.582USD -3,723 60.89 Loss of -1,105 on sale
2025-06-20SELL-8679.98080.770 80.691USD -6,939 60.44 Loss of -1,742 on sale
2025-05-30BUY2,35073.35075.275 75.083USD 176,444 58.37
2025-05-23BUY3576.89077.085 77.065USD 2,697 57.62
2025-05-19SELL-3575.58076.890 76.759USD -2,687 57.04 Loss of -690 on sale
2025-05-15SELL-10575.07075.090 75.088USD -7,884 56.73 Loss of -1,928 on sale
2025-05-12SELL-3576.70079.170 78.923USD -2,762 56.24 Loss of -794 on sale
2025-05-09SELL-3576.78078.555 78.378USD -2,743 56.05 Loss of -781 on sale
2025-04-30SELL-3574.86075.700 75.616USD -2,647 54.75 Loss of -730 on sale
2025-04-24SELL-7074.23074.280 74.275USD -5,199 53.97 Loss of -1,421 on sale
2025-04-17SELL-3569.98070.510 70.457USD -2,466 53.09 Loss of -608 on sale
2025-04-15SELL-10570.25070.360 70.349USD -7,387 52.72 Loss of -1,851 on sale
2025-04-14SELL-10570.00070.400 70.360USD -7,388 52.53 Loss of -1,872 on sale
2025-04-09SELL-14063.27065.350 65.142USD -9,120 52.12 Loss of -1,823 on sale
2025-04-07SELL-24569.64069.970 69.937USD -17,135 51.84 Loss of -4,434 on sale
2025-04-04SELL-35067.48073.000 72.448USD -25,357 51.66 Loss of -7,277 on sale
2025-03-31BUY3571.45073.940 73.691USD 2,579 50.94
2025-03-19SELL-7048.78050.385 50.224USD -3,516 50.58 Profit of 25 on sale
2025-03-14SELL-21049.34050.230 50.141USD -10,530 50.61 Profit of 99 on sale
2025-03-13SELL-7049.03050.130 50.020USD -3,501 50.63 Profit of 43 on sale
2025-03-12SELL-1,19046.70047.130 47.087USD -56,034 50.69 Profit of 4,290 on sale
2025-03-07SELL-7044.78045.750 45.653USD -3,196 50.98 Profit of 373 on sale
2025-03-06SELL-10544.94045.660 45.588USD -4,787 51.07 Profit of 576 on sale
2025-03-03SELL-3545.80049.795 49.395USD -1,729 51.36 Profit of 69 on sale
2025-02-28SELL-21048.82049.530 49.459USD -10,386 51.40 Profit of 408 on sale
2025-02-26SELL-3545.10047.270 47.053USD -1,647 51.62 Profit of 160 on sale
2025-02-25SELL-10544.86045.150 45.121USD -4,738 51.73 Profit of 694 on sale
2025-02-18BUY17548.07050.930 50.644USD 8,863 52.20
2025-02-13BUY3551.33051.420 51.411USD 1,799 52.34
2025-02-12BUY3550.25050.330 50.322USD 1,761 52.38
2025-02-11BUY10549.40050.000 49.940USD 5,244 52.44
2025-02-06BUY31550.98051.270 51.241USD 16,141 52.57
2025-01-27BUY3546.81049.045 48.821USD 1,709 53.27
2024-12-30BUY17545.30045.460 45.444USD 7,953 54.05
2024-12-06BUY14049.15050.000 49.915USD 6,988 54.64
2024-12-05BUY3549.65050.650 50.550USD 1,769 54.81
2024-12-04BUY17550.67052.420 52.245USD 9,143 54.96
2024-11-29BUY17552.71055.271 55.015USD 9,628 55.40
2024-11-27BUY14055.84058.880 58.576USD 8,201 55.36
2024-11-26BUY3558.34059.315 59.217USD 2,073 55.23
2024-11-25BUY2,09057.22060.920 60.550USD 126,549 55.13
2024-11-21BUY14054.63055.970 55.836USD 7,817 55.02
2024-11-20BUY8454.83055.505 55.438USD 4,657 55.03
2024-11-18BUY33651.64053.025 52.887USD 17,770 55.45
2024-11-12BUY22457.31059.450 59.236USD 13,269 55.32
2024-11-08BUY14057.05058.360 58.229USD 8,152 55.20
2024-11-07BUY42057.11059.360 59.135USD 24,837 55.05
2024-11-06BUY5656.86058.680 58.498USD 3,276 54.90
2024-10-31BUY2855.06056.260 56.140USD 1,572 54.42
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SLNO

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19608,8650745,85881.6%
2025-09-181,241,9035,3011,548,86780.2%
2025-09-17518,87701,080,25548.0%
2025-09-16330,132451,290,84225.6%
2025-09-15280,2000950,97329.5%
2025-09-12407,554501,253,80232.5%
2025-09-11440,18317,4031,092,27540.3%
2025-09-101,588,94288,9844,369,44936.4%
2025-09-09183,9680395,05246.6%
2025-09-08187,8580270,19869.5%
2025-09-05143,982318247,25758.2%
2025-09-04318,9531,806490,39865.0%
2025-09-03206,7040361,80957.1%
2025-09-02327,0819,078458,59671.3%
2025-08-29181,245488299,74160.5%
2025-08-28227,1901,400366,57162.0%
2025-08-27354,2110469,38175.5%
2025-08-26278,8250541,50351.5%
2025-08-25183,662978426,42143.1%
2025-08-22271,6971,335466,63658.2%
2025-08-21411,708618577,05271.3%
2025-08-20376,8470653,20157.7%
2025-08-19239,9000600,56939.9%
2025-08-18356,04717,859784,49045.4%
2025-08-151,511,40711,6093,088,69248.9%
2025-08-14677,905200,6571,137,35959.6%
2025-08-13617,389338,747970,53563.6%
2025-08-12320,068158,746411,31877.8%
2025-08-11489,908198,345807,18560.7%
2025-08-08265,8980354,10775.1%
2025-08-07376,234105548,37168.6%
2025-08-06129,95420387,93833.5%
2025-08-05197,763372317,73662.2%
2025-08-04131,501245245,30753.6%
2025-08-01236,3410441,05453.6%
2025-07-31259,4400641,49440.4%
2025-07-30217,19857642,88233.8%
2025-07-29238,6630589,01640.5%
2025-07-28207,9180536,74538.7%
2025-07-25226,63791446,49750.8%
2025-07-24214,977274395,24754.4%
2025-07-23220,2840305,23972.2%
2025-07-22266,909485472,28656.5%
2025-07-21240,86845385,47062.5%
2025-07-18207,76086389,27053.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy